Mangoceuticals, Inc. Common Stock (MGRX) earnings · rev $456.0K
These earnings events as JSON? API free 100/dayMangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
This MGRX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
When the next MGRX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 26.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full MGRX research stays on the stock page; the tape stays on the quote page.
MGRX earnings FAQ
What are MGRX's latest revenue and net income?
Latest cached Mangoceuticals, Inc. Common Stock (MGRX) revenue for Dec 31, 2025 was $456.0K. Net income was -$20.6M. Statements: https://lician.com/financials/mgrx
What is MGRX's latest diluted EPS?
Latest cached Mangoceuticals, Inc. Common Stock (MGRX) diluted EPS for Dec 31, 2025 was -$2.05.
What period does the latest MGRX earnings print cover?
The latest cached Mangoceuticals, Inc. Common Stock (MGRX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did MGRX revenue change from the prior cached period?
Cached Mangoceuticals, Inc. Common Stock (MGRX) revenue was down 26.0% from $615.9K (Dec 31, 2024) to $456.0K (Dec 31, 2025). Statements: https://lician.com/financials/mgrx
Where are MGRX earnings listed?
Cached earnings facts for Mangoceuticals, Inc. Common Stock (MGRX) are listed at https://lician.com/earnings/mgrx. Statements: https://lician.com/financials/mgrx
Not investment advice.